Want to join the conversation?
Globally, $AMGN's product sales grew 6% in 3Q15 and US business grew 20%. International business grew 3% YoverY, excluding the negative impact of FX. Repatha is expected to be approved in Japan in 1H16. Kyprolis, which grew 46% in 3Q15, is expected to be approved in Europe, Canada and parts of South America and Asia by year-end.
$SBUX launched its annual “Starbucks for Life” competition in the U.S. and Canada. The winner of the competition will receive a credit of one drink or food item per day for a duration of 30 years.
$T shares rose 1.8%, as a big boost for the S&P 500. The company said its new streaming television service DirectTV has so far exceeded expectations.
$TXMD flying high.. anyone here to catch..?
$CMG crashing. There seems to be nothing good to read about this company.